Coronavirus Update: Can IL-6 Drugs Cut Deaths? Kevzara Trials Start In Worst Hit Countries
Plus: J&J's Vaccine Could Be Ready By Early 2021
Executive Summary
News from around the biopharma sector and its efforts to meet the challenges posed by the coronavirus pandemic.